DBM-1152A

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameDBM-1152A
Drug Alias NameDBM-1152ADBM1152A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonistsMuscarinic acetylcholine receptor M3 antagonists
TargetsBeta-2 adrenergic receptorMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsPulmonary EmphysemaPulmonary Disease, Chronic ObstructiveBronchial Spasm +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Shuobai Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAnhui Shuobai Pharmaceutical Co LtdLivzon Pharmaceutical Group IncBeijing Shuobai Pharmaceutical Technology Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsPulmonary EmphysemaPulmonary Disease, Chronic ObstructiveBronchial Spasm +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A